血清降钙素原、血乳酸、内毒素检测在评估重症肺炎合并脓毒症病情进展及预后中的价值

陈斯丽, 朱武, 张群

陈斯丽, 朱武, 张群. 血清降钙素原、血乳酸、内毒素检测在评估重症肺炎合并脓毒症病情进展及预后中的价值[J]. 实用临床医药杂志, 2019, 23(19): 86-89. DOI: 10.7619/jcmp.201919023
引用本文: 陈斯丽, 朱武, 张群. 血清降钙素原、血乳酸、内毒素检测在评估重症肺炎合并脓毒症病情进展及预后中的价值[J]. 实用临床医药杂志, 2019, 23(19): 86-89. DOI: 10.7619/jcmp.201919023
CHEN Sili, ZHU Wu, ZHANG Qun. Value of serum procalcitonin, lactic acid and endotoxindetections in evaluating progress of disease and prognosis in patients with severe pneumonia complicated with sepsis[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 86-89. DOI: 10.7619/jcmp.201919023
Citation: CHEN Sili, ZHU Wu, ZHANG Qun. Value of serum procalcitonin, lactic acid and endotoxindetections in evaluating progress of disease and prognosis in patients with severe pneumonia complicated with sepsis[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 86-89. DOI: 10.7619/jcmp.201919023

血清降钙素原、血乳酸、内毒素检测在评估重症肺炎合并脓毒症病情进展及预后中的价值

详细信息
    通讯作者:

    张群

  • 中图分类号: R563.1

Value of serum procalcitonin, lactic acid and endotoxindetections in evaluating progress of disease and prognosis in patients with severe pneumonia complicated with sepsis

  • 摘要:
      目的  探讨血清降钙素原(PCT)、血乳酸(Lac)、内毒素(LPS)检测在评估重症肺炎合并脓毒症病情进展及预后中的价值。
      方法  回顾性分析90例重症肺炎合并脓毒症患者的临床资料,入院后均行急性生理与慢性健康评分(APACHE Ⅱ评分)。根据患者脓毒症病情程度分为脓毒症组(n=37)、严重脓毒症组(n=35)和脓毒症休克组(n=18), 根据住院预后生存情况分为生存组(n=74)和死亡组(n=16)。检测患者入住ICU后24 h内的血清PCT、Lac、LPS水平,比较3组上述指标差异。采用Pearson法分析血清PCT、Lac、内毒素水平与APACHE Ⅱ评分的相关性。
      结果  3组的血清PCT、Lac、LPS水平两两比较,差异均有统计学意义(P < 0.05)。生存组血清PCT、Lac、LPS水平显著低于死亡组(P < 0.05)。重症肺炎合并脓毒症患者血清PCT、Lac、LPS水平与入院APACHE Ⅱ评分均呈显著正相关(P < 0.05)。
      结论  早期加强血清PCT、Lac、LPS水平检测,对评估重症肺炎合并脓毒症病情进展、指导临床干预措施和改善预后有重要意义。
    Abstract:
      Objective  To explore the value of serum procalcitonin (PCT), lactic acid (Lac) and endotoxin (LPS) detection in evaluating the progress of disease and prognosis in patients with severe pneumonia complicated with sepsis.
      Methods  The clinical materials of 90 patients with severe pneumonia complicated with sepsis were retrospectively analyzed. After hospital admission, all the patients were evaluated by the Acute Physiology and Chronic Health Score (APACHE Ⅱ). The patients were conducted with evaluation of divided into sepsis group (n=37), severe sepsis group (n=35) and septic shock group (n=18) according to severity of disease, and they were also divided into survival group (n=74) and death group (n=16) according to the prognosis. Serum PCT, Lac and LPS levels were measured within 24 hours after ICU admission, and the differences among the three groups were compared. Pearson method was used to analyze the correlations between serum PCT, Lac, endotoxin level and APACHE Ⅱscore.
      Results  There were significant differences in levels of PCT, Lac and LPS among three groups (P < 0.05). Serum PCT, Lac and LPS levels in survival group were significantly lower than those in death group (P < 0.05). Serum PCT, Lac and LPS levels in severe pneumonia patients with sepsis were positively correlated with APACHE Ⅱscores on hospital admission (P < 0.05).
      Conclusion  Early detections of serum PCT, Lac and LPS levels are of great significance in evaluating the progress of disease in severe pneumonia patients complicated with sepsis, guiding clinical intervention and improving prognosis.
  • 表  1   3组血清PCT、Lac、LPS水平比较(x±s)

    指标 脓毒症组(n=37) 严重脓毒症组(n=35) 脓毒症休克组(n=18)
    PCT/(ng/mL) 1.37±0.72 3.58±1.18* 5.93±1.42*#
    Lac/(mmol/L) 1.95±0.61 3.74±1.07* 6.25±1.58*#
    LPS/(pg/mL) 12.51±2.35 17.48±3.72* 25.36±4.45*#
    PCT:降钙素原; Lac:血乳酸; LPS:内毒素。
    与脓毒症组比较, *P < 0.05;与严重脓毒症组比较, #P < 0.05。
    下载: 导出CSV

    表  2   生存组与死亡组血清PCT、Lac、LPS水平比较(x±s)

    组别 n PCT/(ng/mL) Lac/(mmol/L) LPS/(pg/mL)
    生存组 74 2.72±0.75 2.85±0.81 14.32±4.03
    死亡组 16 5.93±1.62* 6.04±1.94* 26.18±3.96*
    PCT:降钙素原; Lac:血乳酸; LPS:内毒素。
    与生存组比较, *P < 0.05。
    下载: 导出CSV
  • [1] 陈佑生, 魏蕾.自拟清热解毒汤保留灌肠联合乌司他丁治疗重症肺炎合并脓毒症疗效及对凝血纤溶系统及免疫炎性反应影响[J].现代中西医结合杂志, 2017, 26(35): 3949-3951. doi: 10.3969/j.issn.1008-8849.2017.35.027
    [2]

    Gonçalves M C, Horewicz V V, Lückemeyer D D, et al. Experimental Sepsis Severity Score Associated to Mortality and Bacterial Spreading is Related to Bacterial Load and Inflammatory Profile of Different Tissues[J]. Inflammation, 2017, 40(5): 1-13. http://www.ncbi.nlm.nih.gov/pubmed/28567497

    [3]

    Liu Y, Yang W, Wei J. Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis[J]. Iranian Journal of Public Health, 2017, 46(11): 1535-1539. http://www.ncbi.nlm.nih.gov/pubmed/29167772

    [4] 瞿介明, 曹彬.中国成人社区获得性肺炎诊断和治疗指南(2016年版)修订要点[J].中华结核和呼吸杂志, 2016, 39(4): 241-242. doi: 10.3760/cma.j.issn.1001-0939.2016.04.001
    [5] 杜春雨, 王佳贺.老年重症肺炎临床特点及诊治进展[J].实用老年医学, 2018, 32(10): 13-16. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLA201810005.htm
    [6] 陈晶晶, 陆国平. 2018成人脓毒症管理指南更新解读[J].中国小儿急救医学, 2018, 25(7): 481-483. doi: 10.3760/cma.j.issn.1673-4912.2018.07.001
    [7] 马斌, 封凯旋, 凌杰兵.重症肺炎合并脓毒症患者血栓弹力图与凝血指标及炎症相关因子观察[J].哈尔滨医科大学学报, 2018, 52(6): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-HYDX201806019.htm
    [8] 李晓华, 童岚, 贾丹.降钙素原、红细胞宽度对重症肺炎预后的评估价值[J].中国实验诊断学, 2018, 22(10): 43-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD201810012.htm
    [9]

    Numan Y, Jawaid Y, Hirzallah H, et al. Ammonia vs. Lactic Acid in Predicting Positivity of Microbial Culture in Sepsis: The ALPS Pilot Study[J]. Journal of Clinical Medicine, 2018, 7(8): 182-189. doi: 10.3390/jcm7080182

    [10] 张欢, 王敏, 张莉, 等.脓毒症患者血浆内毒素水平及肠道菌群变化分析[J].临床医学研究与实践, 2018, 3(33): 9-11. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS201833002.htm
    [11] 王海霞, 彭亚岚, 吕林.血清降钙素原水平与重症肺炎伴ARDS发病的相关性及对病情严重程度的评估价值[J].海南医学, 2018, 29(10): 71-74. https://www.cnki.com.cn/Article/CJFDTOTAL-HAIN201810021.htm
    [12] 颜海鹏, 卢秀兰, 仇君, 等.血乳酸在脓毒症患儿病情及预后评价中的意义[J].中国当代儿科杂志, 2016, 18(6): 506-510. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201606010.htm
    [13] 刘振国, 王婷, 王顺达, 等.重症肺炎并发脓毒症患者血清降钙素原、血乳酸及内毒素水平的相关研究[J].现代检验医学杂志, 2017, 32(2): 95-97, 164. doi: 10.3969/j.issn.1671-7414.2017.02.026
    [14] 陈吉威.重症肺炎患者血清降钙素原、乳酸水平和乳酸清除率的变化及临床意义[J].中国基层医药, 2018, 25(4): 453-456. doi: 10.3760/cma.j.issn.1008-6706.2018.04.012
    [15] 付艳华, 金湘东, 索冬卫, 等. APACHE Ⅲ评分及血清降钙素原对老年重症肺炎的病情及预后评估价值[J].淮海医药, 2017, 35(5): 529-531. https://www.cnki.com.cn/Article/CJFDTOTAL-HHYY201705009.htm
    [16] 秦海萍, 庄建晴, 曹维锷, 等.降钙素原联合内毒素检测对老年脓毒症的临床意义[J].贵阳医学院学报, 2016, 41(4): 483-486, 490. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB201604033.htm
    [17] 郝琴, 谢星星, 常静.肺炎合并脓毒症患者PCT、hs-CRP检测的临床意义[J].检验医学与临床, 2017, 14(5): 714-716. doi: 10.3969/j.issn.1672-9455.2017.05.046
    [18] 李虹光, 徐晓军, 杨建荣, 等.肺炎合并脓毒症患儿血清降钙素原水平变化的临床意义[J].解放军预防医学杂志, 2016, 34(5): 709-711. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX201605025.htm
  • 期刊类型引用(10)

    1. 徐颖. 多层螺旋CT联合核磁共振成像增强扫描在胰腺癌及慢性胰腺炎鉴别诊断中的价值分析. 大医生. 2024(01): 127-129 . 百度学术
    2. 高成强,毕司星,李立新. CT平扫联合增强扫描在胰腺癌诊断中的应用价值. 影像研究与医学应用. 2024(02): 31-33 . 百度学术
    3. 侯胜楠. CT、MRI增强扫描对胰腺癌与慢性胰腺炎的鉴别诊断价值. 中华养生保健. 2024(07): 176-180 . 百度学术
    4. 柳群力,朱鸷翔. CT联合分泌型卷曲受体蛋白4及可溶性生长刺激表达基因2蛋白对恶性胆道梗阻患者术后并发胰腺炎的诊断价值. 实用临床医药杂志. 2024(05): 59-62+67 . 本站查看
    5. 郑北. 联合应用CT、MRI增强扫描鉴别诊断胰腺癌与慢性胰腺炎的价值. 中国医疗器械信息. 2024(08): 12-14+25 . 百度学术
    6. 曹中立. 多层螺旋CT在胰腺癌术前评估及诊断中的应用价值. 影像研究与医学应用. 2024(10): 132-134 . 百度学术
    7. 杨懿,黄新蓉. MRI与CT检查诊断急性胰腺炎的价值比较研究. 影像研究与医学应用. 2024(14): 135-137+140 . 百度学术
    8. 董源涛,尚金红,袁燕丽. MRI联合CT在胰腺肿瘤中的诊断价值. 影像研究与医学应用. 2024(16): 137-139 . 百度学术
    9. 游红莲,闫明艳,褚千琨,王芳芳,陈文晶,于根建,王静. 隐匿性小胰腺癌并急性胰腺炎与单纯性急性胰腺炎的CT对比分析. 临床误诊误治. 2024(17): 63-68 . 百度学术
    10. 刘强. 多层螺旋CT与MRI扫描鉴别诊断胰腺癌和胰腺炎的有效性探讨. 影像研究与医学应用. 2024(19): 24-26 . 百度学术

    其他类型引用(1)

表(2)
计量
  • 文章访问数:  305
  • HTML全文浏览量:  218
  • PDF下载量:  7
  • 被引次数: 11
出版历程
  • 收稿日期:  2019-07-08
  • 录用日期:  2019-08-10
  • 网络出版日期:  2021-02-28
  • 发布日期:  2019-10-14

目录

    /

    返回文章
    返回